Baxter 2B1064 - 5% Dextrose And 0.9% Sodium Chloride Injection USP in VIAFLEX Plastic Container, 1000 mL, 24 Per/CS
Baxter 2B1064 Dextrose and Sodium Chloride Injection, USP in VIAFLEX Plastic Container
Dextrose and Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment and caloric supply in single dose containers for intravenous administration. It contains no antimicrobial agents. Composition, osmolarity, pH, ionic concentration and caloric content.
The VIAFLEX plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.
Clinical Pharmacology of Baxter 2B1064 Dextrose and Sodium Chloride Injection, USP in VIAFLEX Plastic Container
Dextrose and Sodium Chloride Injection, USP has value as a source of water, electrolytes, and calories. It is capable of inducing diuresis depending on the clinical condition of the patient.
Baxter 2B1064 Indications and Usage
Dextrose and Sodium Chloride Injection, USP is indicated as a source of water, electrolytes, and calories.
Contraindications of Baxter 2B1064
Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.
Directions for Use of Baxter 2B1064 VIAFLEX Plastic Container
To Open
Tear overwrap down side at slit and remove solution container. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below.
Preparation for Administration
- Suspend container from eyelet support.
- Remove protector from outlet port at bottom of container.
- Attach administration set. Refer to complete directions accompanying set.
Warning
Additives may be incompatible
To add medication before solution administration
- Prepare medication site.
- Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.
- Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.
- Close clamp on the set.
- Prepare medication site.
- Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.
- Remove container from IV pole and/or turn to an upright position.
- Evacuate both ports by squeezing them while container is in the upright position.
- Mix solution and medication thoroughly
- Return container to in-use position and continue administration.
Baxter #2B2454X, 5% Dextrose, 0.9% Sodium Chloride and 40 mEq/L Potassium Chloride Injection, USP, 1000 ml, Viaflex Plastic Container, 14/cs
Baxter #2B1302, *** INACTIVE *** 0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Plastic Container, 96 Per/CS (EXPIRED AUGUST, 2021)
Baxter #2B1302, 0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Plastic Container, Quad Pack (4 bags/overwrap), 96 Per/CS
